| Primary |
| Bronchitis |
14.7% |
| Hypertension |
9.0% |
| Suicide Attempt |
9.0% |
| Sinusitis |
8.1% |
| Pyrexia |
7.1% |
| Cough |
5.7% |
| Nasopharyngitis |
5.2% |
| Respiratory Tract Infection |
4.3% |
| Urinary Tract Infection |
4.3% |
| Ear Infection |
3.8% |
| Multiple Myeloma |
3.8% |
| Pharyngitis |
3.8% |
| Prophylaxis |
3.3% |
| Ill-defined Disorder |
2.8% |
| Infection |
2.8% |
| Lung Disorder |
2.8% |
| Perinephric Abscess |
2.8% |
| Osteoporosis |
2.4% |
| Tracheitis |
2.4% |
| Arthralgia |
1.9% |
|
| Pancreatitis Acute |
11.4% |
| Pyrexia |
7.1% |
| Thrombocytopenia |
7.1% |
| Angioedema |
5.7% |
| Diarrhoea |
5.7% |
| Drug Ineffective |
5.7% |
| Overdose |
5.7% |
| Toxic Epidermal Necrolysis |
5.7% |
| Vomiting |
5.7% |
| Blood Disorder |
4.3% |
| Clostridium Difficile Colitis |
4.3% |
| Hepatitis |
4.3% |
| Pulmonary Alveolar Haemorrhage |
4.3% |
| Renal Failure Acute |
4.3% |
| Vertigo |
4.3% |
| Death |
2.9% |
| Dysphagia |
2.9% |
| Galactorrhoea |
2.9% |
| Gastritis |
2.9% |
| Hyperprolactinaemia |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
33.2% |
| Product Used For Unknown Indication |
9.1% |
| Nasopharyngitis |
8.6% |
| Ill-defined Disorder |
5.7% |
| Pyrexia |
5.7% |
| Hypertension |
5.4% |
| Sinusitis |
3.7% |
| Perinephric Abscess |
3.4% |
| Cough |
3.2% |
| Pain |
2.7% |
| Pharyngitis |
2.7% |
| Pneumonia |
2.5% |
| Depression |
2.0% |
| Hiv Infection |
2.0% |
| Hyperthermia |
2.0% |
| Tonsillitis |
2.0% |
| Upper Respiratory Tract Inflammation |
2.0% |
| Influenza |
1.7% |
| Streptococcal Infection |
1.5% |
| Atrial Fibrillation |
1.2% |
|
| Toxic Epidermal Necrolysis |
20.8% |
| Stevens-johnson Syndrome |
10.4% |
| Clostridium Difficile Colitis |
9.1% |
| Agranulocytosis |
5.2% |
| Hyponatraemia |
5.2% |
| Neutropenia |
5.2% |
| Spina Bifida |
5.2% |
| Syncope |
5.2% |
| Pyrexia |
3.9% |
| Thrombocytopenia |
3.9% |
| Drug Exposure During Pregnancy |
2.6% |
| Foetal Death |
2.6% |
| Galactorrhoea |
2.6% |
| Hallucination, Visual |
2.6% |
| Hyperprolactinaemia |
2.6% |
| Lymphocyte Count Decreased |
2.6% |
| Pancreatitis Acute |
2.6% |
| Pneumonia Mycoplasmal |
2.6% |
| Rash Maculo-papular |
2.6% |
| Rectal Haemorrhage |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
16.5% |
| Hypertension |
7.7% |
| Pneumonia |
7.3% |
| Neuroblastoma |
4.5% |
| Acute Coronary Syndrome |
3.7% |
| Ascites |
3.3% |
| Multiple Myeloma |
3.3% |
| Acute Myeloid Leukaemia |
3.2% |
| Bronchitis |
3.2% |
| Breast Cancer |
3.0% |
| Cardiac Disorder |
2.5% |
| Ill-defined Disorder |
2.5% |
| Peritonitis Bacterial |
2.5% |
| Pain |
2.3% |
| Hepatic Neoplasm Malignant |
2.2% |
| Hepatitis C |
2.2% |
| Epilepsy |
1.8% |
| Premedication |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
|
| Pyrexia |
10.5% |
| Pneumonia |
9.5% |
| Weight Decreased |
8.4% |
| Sinusitis |
7.4% |
| Sepsis |
6.3% |
| Thrombosis In Device |
6.3% |
| Death |
5.3% |
| Diverticulitis |
4.2% |
| Renal Failure Acute |
4.2% |
| Rhabdomyolysis |
4.2% |
| Syncope |
4.2% |
| Urticaria |
4.2% |
| Chest Pain |
3.2% |
| Device Related Infection |
3.2% |
| Epilepsy |
3.2% |
| Fatigue |
3.2% |
| General Physical Health Deterioration |
3.2% |
| Parosmia |
3.2% |
| Septic Shock |
3.2% |
| Stillbirth |
3.2% |
|
| Interacting |
| Atrial Fibrillation |
33.3% |
| Bronchitis |
22.2% |
| Hypertension |
22.2% |
| Hypercholesterolaemia |
11.1% |
| Sinusitis |
11.1% |
|
| Overdose |
50.0% |
| Weight Decreased |
50.0% |
|
